|
Article Cited by others ORIGINAL ARTICLE
Role of metformin, Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) receptor agonists, and orlistat based multidrug therapy in glycemic control, weight loss, and euglycemia in diabesity: A real-world experience
Dutta Deep, Jaisani Ritu, Khandelwal Deepak, Ghosh Soumitra, Malhotra Rajiv, Kalra Sanjay
Year : 2019| Volume: 23| Issue : 4 | Page no: 460-467 | This article has been cited by | | 1 |
Targeting insulin resistance with selected antidiabetic agents prevents menopausal associated central obesity, dysglycemia, and cardiometabolic risk |
|
| | Satish Jankie,Lexley Maureen Pinto Pereira | | | Post Reproductive Health. 2021; 27(1): 45 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Sodium Glucose Co-Transporter 2 Inhibition Does Not Favorably Modify the Physiological Responses to Dietary Counselling in Diabetes-Free, Sedentary Overweight and Obese Adult Humans |
|
| | Shane P.P. Ryan,Alissa A. Newman,Jessie R. Wilburn,Lauren D. Rhoades,S. Raj J. Trikha,Ellen C. Godwin,Hayden M. Schoenberg,Micah L. Battson,Taylor R. Ewell,Gary J. Luckasen,Laurie M. Biela,Christopher L. Melby,Christopher Bell | | | Nutrients. 2020; 12(2): 510 | | | [Pubmed] [Google Scholar] [DOI] | |
|
|
|
|
